Invus Opportunities Partner Ben Tsai Seeks – and Finds – Success in Medtech Investments

Medtech Talk

English - March 22, 2019 04:00 - 30 minutes - 13.9 MB - ★★★★★ - 56 ratings
Investing Business Health & Fitness medtech medical device venture capital health care innovation cardiology start-ups orthopedics digital health fda Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: PreCardia CEO Lisa Wipperman Heine Shares Details on Path to New Role at Stealthy HF Start-Up

Next Episode: KPV’s Amy Belt Raimundo Landed in VC Just Before the Bottom Fell Out. Hear How She Pivoted, Thrived

Benjamin Tsai says his initial plans – or the plans he’d been given – called on him being a doctor. But he quickly saw a greater opportunity working in the life sciences industry. Tsai made a quick run through consulting firms and business school before finding a place at Invus, an investment firm that has operated mostly out of the limelight. In this podcast, Tsai discusses his career, his outlook on Medtech and why Invus – investor in Auris Health and other high-profile deals – is beginning to get out to tell its own story.